New Zealand - English - Medsafe (Medicines Safety Authority)

hospira nz ltd - procaine hydrochloride 2%{relative};   - solution for injection - 2% w/v - active: procaine hydrochloride 2%{relative}   excipient: sodium chloride water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - procaine hydrochloride 2%;  ;   - solution for injection - 2 % - active: procaine hydrochloride 2%     excipient: hydrochloric acid sodium chloride water for injection

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - chloroprocaine hydrochloride 10 mg in 1 ml - nesacaine 1% and 2% injections, in multidose vials with methylparaben as preservative, are indicated for the production of local anesthesia by infiltration and peripheral nerve block. they are not to be used for lumbar or caudal epidural anesthesia. nesacaine-mpf 2% and 3% injections, in single dose vials without preservative and without edta, are indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. nesacaine and nesacaine-mpf injections are not to be used for subarachnoid administration. nesacaine and nesacaine-mpf injections are contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - nesacaine 1% and 2% injections, in multidose vials with methylparaben as preservative, are indicated for the production of local anesthesia by infiltration and peripheral nerve block. they are not to be used for lumbar or caudal epidural anesthesia. nesacaine-mpf 2% and 3% injections, in single dose vials without preservative and without edta, are indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. nesacaine and nesacaine-mpf injections are not to be used for subarachnoid administration. nesacaine and nesacaine-mpf injections are contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

v.m.d. - epinephrine hydrogen tartrate 0.036 mg/ml; procaine hydrochloride 40 mg/ml - solution for injection - epinephrine bitartrate 36 µg/ml; procaine hydrochloride 40 mg/ml - procaine - cattle; horse; sheep; pig

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - nesacaine 1% and 2% injections, in multidose vials with methylparaben as preservative, are indicated for the production of local anesthesia by infiltration and peripheral nerve block. they are not to be used for lumbar or caudal epidural anesthesia. nesacaine-mpf 2% and 3% injections, in single dose vials without preservative and without edta, are indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. nesacaine and nesacaine-mpf injections are not to be used for subarachnoid administration. nesacaine and nesacaine-mpf injections are contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

danberg (m) sdn bhd - procaine benzylpenicillin; dihydrostreptomycin sulphate -

Australia - English - Department of Health (Therapeutic Goods Administration)

oxybuprocaine hydrochloride -

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - neomycin sulfate, procaine penicillin g - suspension for injection - 100/200 mg/ml - penicillins, combinations with other antibacterials - bovine, equine - food, porcine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

bausch & lomb uk limited - oxybuprocaine hydrochloride - eye drops, solution - 0.4 percent weight/volume - local anesthetics; oxybuprocaine